现代药物与临床2024,Vol.39Issue(1) :94-101.DOI:10.7501/j.issn.1674-5515.2024.01.012

HPLC多指标成分定量联合化学计量学评价不同产地茜草

Evaluation of Rubiae Radix from different regions by HPLC multi index components combined with chemometrics

姜云 乔春凤 刘华 乔亚红 李俊涛
现代药物与临床2024,Vol.39Issue(1) :94-101.DOI:10.7501/j.issn.1674-5515.2024.01.012

HPLC多指标成分定量联合化学计量学评价不同产地茜草

Evaluation of Rubiae Radix from different regions by HPLC multi index components combined with chemometrics

姜云 1乔春凤 1刘华 1乔亚红 1李俊涛2
扫码查看

作者信息

  • 1. 郑州颐和医院 药学部,河南 郑州 450047
  • 2. 河南省医药科学研究院 药物研究所,河南 郑州 450052
  • 折叠

摘要

目的 建立茜草多指标成分定量联合化学计量学评价不同产地茜草的质量.方法 采用高效液相色谱法测定 8 省区 18 批茜草中新橙皮苷、山柰酚、茜草素、异茜草素、羟基茜草素、1,3,6-三羟基-2-甲基蒽醌、大叶茜草素、去氢-α-拉杷醌、β-谷甾醇和异落叶松脂素,并采用主成分分析、正交偏最小二乘法-判别分析、灰色关联度分析对测定结果进行评价.结果 相同产区的茜草,质量较接近;共找到 4 个差异性标志成分,其影响显著性排序为大叶茜草素>茜草素>1,3,6-三羟基-2-甲基蒽醌>羟基茜草素;陕西、河南和安徽所产的茜草整体质量较好.结论 方法便捷、准确,易于推广,可以更全面、更系统地评价茜草的质量.

Abstract

Objective To establish a method for quality evaluation of Rubiae Radix by HPLC combined with chemometrics.Methods The contents of neohesperidin,kaempferol,alizarin,xanthopurpurin,purpurin,1,3,6-trihydroxy-2-methylanthraquinone,mollugin,dehydro-α-lapachone,β-sitosterol,and isolariciresinol in 18 batches of Rubiae Radix collected from 8 provinces were determined by HPLC method,and the results were analyzed by principal component analysis(PCA),orthogonal partial least squares discriminant analysis(OPLS-DA),and grey relational analysis(GRA)method.Results Rubiae Radix from the same production area had similar quality.A total of four differential marker components were found,and their significance was ranked as follows:mollugin>alizarin>1,3,6-trihydroxy-2-methylanthraquinone>purpurin.The overall quality of Rubiae Radix in Shaanxi,Henan,and Anhui Province was good.Conclusion The method is convenient,accurate,and easy to promote,which can comprehensively and systematically evaluate the quality of Rubiae Radix.

关键词

茜草/大叶茜草素/茜草素/1,3,6-三羟基-2-甲基蒽醌/羟基茜草素/高效液相色谱/主成分分析/正交偏最小二乘法-判别分析/灰色关联度分析

Key words

Rubiae Radix/mollugin/alizarin/1,3,6-trihydroxy-2-methylanthraquinone/purpurin/HPLC/PCA/OPLS-DA/GRA

引用本文复制引用

基金项目

河南省医学科技攻关计划省部共建指导性计划重点项目(SBGJ202002105)

出版年

2024
现代药物与临床
天津药物研究院,中国药学会

现代药物与临床

CSTPCD
影响因子:1.179
ISSN:1674-5515
被引量1
参考文献量18
段落导航相关论文